Steven R. Altman - Dec 15, 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Steven Altman
Stock symbol
DXCM
Transactions as of
Dec 15, 2023
Transactions value $
-$245,548
Form type
4
Date filed
12/18/2023, 04:31 PM
Previous filing
Dec 13, 2023
Next filing
Jan 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$246K -2K -3.53% $122.77 54.7K Dec 15, 2023 by Trust F1, F2
holding DXCM Common Stock 2.89K Dec 15, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 On May 30, 2023, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2 Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.